NCT00659360 2018-06-29AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue SarcomaNational Cancer Institute (NCI)Phase 2 Completed17 enrolled 9 charts
NCT00558272 2013-05-27Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone DiseaseAstraZenecaPhase 2 Completed139 enrolled 23 charts